BEAT - BioTelemetry, Inc.
| Previous Close | 47.79 |
| Open | 48.01 |
| Bid | 48.09 x 800 |
| Ask | 48.12 x 800 |
| Day's Range | 47.55 - 48.39 |
| 52 Week Range | 41.15 - 80.92 |
| Volume | 336,643 |
| Avg. Volume | 621,312 |
| Market Cap | 1.626B |
| Beta (3Y Monthly) | 1.77 |
| PE Ratio (TTM) | 35.71 |
| EPS (TTM) | 1.35 |
| Earnings Date | Jul 23, 2019 - Jul 29, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80.67 |
- Simply Wall St.•8 days ago
Does BioTelemetry, Inc. (NASDAQ:BEAT) Have A High Beta?
If you own shares in BioTelemetry, Inc. (NASDAQ:BEAT) then it's worth thinking about how it contributes to the...
- GlobeNewswire•9 days ago
BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards
BioTelemetry (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that Joseph H. Capper, President and CEO, has been awarded the 2019 Healthcare CEO of the Year Award by the Philadelphia Alliance for Capital and Technologies, or PACT. The Healthcare CEO of the Year Award recognizes leaders for their management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company. “Each day we work with our customers and business partners to make a difference in the lives of our patients and communities,” said Joseph H. Capper, President and CEO of BioTelemetry.
- Investor's Business Daily•18 days ago
Why You Should Keep An Eye On These Leading Health Care Stocks
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
- Insider Monkey•24 days ago
Here’s What Hedge Funds Think About BioTelemetry, Inc. (BEAT)
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing […]
- Thomson Reuters StreetEvents•25 days ago
Edited Transcript of BEAT earnings conference call or presentation 25-Apr-19 9:00pm GMT
Q1 2019 BioTelemetry Inc Earnings Call
Motley Fool•29 days agoBioTelemetry Inc (BEAT) Q1 2019 Earnings Call Transcript
BEAT earnings call for the period ending March 31, 2019.
- Benzinga•29 days ago
The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ...
- Associated Press•29 days ago
BioTelemetry: 1Q Earnings Snapshot
On a per-share basis, the Malvern, Pennsylvania-based company said it had profit of 32 cents. Earnings, adjusted for one-time gains and costs, were 42 cents per share. The results met Wall Street expectations. ...
- GlobeNewswire•29 days ago
BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
Achieves Record Quarterly Revenue Raises Full Year 2019 Guidance MALVERN, Pa., April 25, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology.
- Simply Wall St.•last month
Should You Investigate BioTelemetry, Inc. (NASDAQ:BEAT) At US$58.57?
BioTelemetry, Inc. (NASDAQ:BEAT), which is in the healthcare business, and is based in United States, received a lot of attention from a substantial price movement on the NASDAQGS ove...
- Zacks•last month
BioTelemetry (BEAT) to Report Q1 Earnings: What's in Store?
Products like MCT and Ware Holter are likely to aid BioTelemetry (BEAT) in Q1.
- Zacks•last month
Top Stock Picks for the Week of Apr 22, 2019
Tracey Ryniec and Kevin Cook look at two highly rated stocks.
- Zacks•last month
BioTelemetry (BEAT) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, BioTelemetry (BEAT) closed at $55.13, marking a +0.35% move from the previous day.
- GlobeNewswire•last month
BioTelemetry, Inc. to Release First Quarter 2019 Earnings Results on April 25, 2019
MALVERN, Pa., April 18, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2019 earnings on Thursday, April 25 at 4:00 PM Eastern Time. The BioTelemetry.
- Zacks•last month
BioTelemetry (BEAT) Earnings Expected to Grow: Should You Buy?
BioTelemetry (BEAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•last month
Teladoc's Partnership to Form Pediatric Telehealth Platform
Teladoc (TDOC) teams up with Cincinnati Children's Hospital Medical Center to launch consumer pediatric telehealth platform.
- Zacks•2 months ago
Has BioTelemetry (BEAT) Outpaced Other Medical Stocks This Year?
Is (BEAT) Outperforming Other Medical Stocks This Year?
- Zacks•2 months ago
BioTelemetry (BEAT) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, BioTelemetry (BEAT) closed at $60.03, marking a -0.94% move from the previous day.
- Simply Wall St.•2 months ago
BioTelemetry (NASDAQ:BEAT) Shareholders Have Enjoyed A Whopping 538% Share Price Gain
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! It might be of some concern to shareholders to see the BioTelemetry, Inc. (NASDAQ:BEAT) share price down 15% in the l...
- Zacks•2 months ago
BioTelemetry (BEAT) Gains But Lags Market: What You Should Know
BioTelemetry (BEAT) closed the most recent trading day at $68.46, moving +0.87% from the previous trading session.
- Motley Fool•2 months ago
Dear Apple, Is My Heart OK?
Results from the Apple Heart Study suggest wearables like watches could someday reshape healthcare.
- Zacks•2 months ago
Teladoc to Acquire MedecinDirect, Expand Overseas Business
Teladoc's (TDOC) acquisition of MedecinDirect will aid it in enhancing presence in expanding virtual care market in France.
